TCON - TRACON Pharmaceuticals Inc. (TCON) CEO Charles Theuer on Q4 2021 Results - Earnings Call Transcript

TRACON Pharmaceuticals, Inc. (TCON) Q4 2021 Earnings Conference Call March 15, 2022 04:30 PM ET Company Participants Charles Theuer - President & Chief Executive Officer Scott Brown - Chief Financial Officer Conference Call Participants Maury Raycroft - Jefferies Ed White - H.C. Wainwright Joel Beatty - Baird Nick Abbott - Wells Fargo Matthew Cross - Alliance Global Presentation Operator Good day, ladies and gentlemen, and welcome to TRACON Pharmaceuticals Fourth Quarter and Year Ended 2021 Earnings Conference Call. At this time, all callers are in a listen-only mode. After the speakers' prepared remarks, we will conduct a question-and-answer session and instructions will be given at that time. During today's call, we will be making certain forward-looking statements including statements regarding expected timing of clinical trials and results, regulatory activities, future expenses and cash runway and our development plans and strategy. These statements are subject to various risks that are described

For further details see:

TRACON Pharmaceuticals, Inc. (TCON) CEO Charles Theuer on Q4 2021 Results - Earnings Call Transcript